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Abstract
Background Obesity is associated with respiratory symp-
toms and impaired pulmonary function, which could in-
crease the risk of complications after bariatric surgery. The
purpose of this study is to assess the relationship between
pulmonary function parameters before, and the risk of
complications after, laparoscopic bariatric surgery.
Methods This prospective study included patients (age 18–
60, BMI >35 kg/m2), who were eligible for bariatric surgery.
Spirometry was performed in all patients. Complications up
to 30 days after bariatric surgery were recorded.
Results Four hundred eighty-five patients were included
(304 laparoscopic sleeve gastrectomy, 181 laparoscopic
gastric bypass). There were 53 complications (8 pulmonary,
27 surgical, 14 infectious, 4 other) in 50 patients (10 %).
There were 35 re-admissions (7.2 %), and 17 re-
laparoscopies (3.5 %). Subjects with and without complica-
tions did not differ significantly with respect to demo-
graphics, weight, BMI, abdominal circumference or fat
percentage. Subjects with complications had a significantly
lower mean FEV1 (mean 86.9 % predicted) and FVC
(95.6 % predicted) compared to patients without compli-
cations (95.9 % predicted, p=0.005, and 100.1 % pre-
dicted, p=0.045, respectively). After adjustment for age,
gender, BMI, and smoking, abnormal spirometry value
remained the single predictive covariable of postoperative
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complications: FEV1/FVC <70 % adjusted OR 3.1 (95%CI
1.4–6.8, p=0.006) and ΔFEV1 ≥12 % adjusted OR 2.9
(95 %CI 1.3–6.6, p=0.010).
Conclusions The risk of pulmonary complications after lap-
aroscopic bariatric surgery is low. However, subjects with
abnormal spirometry test results have a threefold risk of
complications after laparoscopic bariatric surgery. Preoper-
ative pulmonary function testing might be useful to predict
the risk of complications of laparoscopic bariatric surgery.
Keywords Pulmonary function test . Morbid obesity .
Obesity . Bariatric surgery . Complications
Abbreviations
ASA American Society of Anesthesiologists
BMI Body mass index
COPD Chronic obstructive pulmonary disease
ESS Epworth sleepiness scale
FeNO Exhaled nitric oxide
FEV1 Forced expiratory volume in 1 s
FRC Functional respiratory capacity
FVC Forced vital capacity
GERD Gastroesophageal reflux disease
OSAS Obstructive sleep apnea syndrome
RV Residual volume
TLC Total lung capacity
Introduction
Obesity is becoming a worldwide epidemic. In 2008, the
WHO estimated that one out of ten persons of the world’s
adult population was obese [1]. Accordingly, the number of
bariatric surgery procedures being performed is increasing
every year, with a 22-fold increase between 1996 and 2008
[2]. The postoperative morbidity rate after bariatric surgery
is about 5 %. Gupta showed in a large cohort study that
postoperative pneumonia and respiratory failure, despite
being infrequent complications of bariatric surgery, account
for one fifth of the morbidity. Moreover, these complica-
tions are also associated with increased mortality [3] and
represent largest attributable costs of all complications [4].
The prevention of complications of bariatric surgery is of
great importance, especially since the operation is elective and
complications are difficult to treat in this group of morbidly
obese patients. Obesity is found to be a risk factor for the
development of postoperative pulmonary complications after
abdominal surgery [5]. Obesity-related comorbidities may
predispose obese patients to postoperative complications, as
illustrated by the observation that asthma is 50 % more prev-
alent among obese subjects [6] and obese asthma patients
have worse asthma control [7], which might predispose them
to postoperative complications.
Current guidelines do not indicate pulmonary function
testing in patients without evidence of pre-existing lung
disease who are evaluated for non-thoracic surgical proce-
dures. It is, however, questionable whether this also holds
true for the morbidly obese. Spirometry could identify pa-
tients who are at risk for complications, although this is not
the current consensus [8]. Spirometry is mandatory in pa-
tients who are heavy smokers, or have complaints of
dyspnea or cough [9]. However, there is a poor correlation
between lung function measurements and the presence of
symptoms [10], also among the morbidly obese.
Hamoui has shown that pulmonary function parameters
prior to open bariatric surgery are predictive for complica-
tions after bariatric surgery [11]. However, bariatric surgery
has developed during the last decade into a laparoscopic
procedure which is considered to be a safer treatment than
open surgery [12]. Laparoscopic procedures are typically
associated with less postoperative pain, decreased opioid
use, and earlier mobilization when compared with open
procedures [13]. However, the prognostic added value of
pulmonary function testing before laparoscopic bariatric
surgery is unknown.
Since laparoscopic procedures are now standard, and
little is known about the value of pulmonary function tests
before laparoscopic bariatric surgery, we performed a
prospective study to compare the predictive relationship
between lung function parameters before laparoscopic
bariatric surgery and the postoperative 30-days risk of com-
plications, taking comorbidities, demographic, and anthro-
pomorphic features into account. We hypothesized that
abnormal lung function test results before surgery could
identify patients at risk for complications of bariatric
surgery.
Materials and Methods
Study Population
The subjects included in this study were consecutive
patients who underwent a preoperative screening program
for bariatric surgery in the Sint Franciscus Gasthuis in
Rotterdam, the Netherlands, between October 2009 and
November 2011. Eligibility criteria for bariatric surgery
were: age between 18 and 60 years, body mass index
(BMI) either >40 or >35 kg/m2 combined with the presence
of comorbidity such as diabetes mellitus, hypertension or
proven obstructive sleep apnea syndrome (OSAS). Prior to
surgery, subjects underwent physical examinations that in-
cluded routine assessment of anthropometry and pulmonary
function. Height and weight were measured wearing light
clothes and no shoes. Body mass index was calculated as
weight (in kilogram) divided by height (in meter squared).
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Abdominal circumference was measured directly to the
body surface midway between the lower rib margin and
the ileac crest. Fat free mass and fat weight (in kilogram
and percentage of body weight) were measured using elec-
trical impedance analysis (Bodystat 1500, Bodystat Ltd,
British Isles) [14]. The presence of comorbidities was de-
fined as follows: diabetes mellitus, hypertension or hyper-
lipidemia all by the use of medication, the presence of the
metabolic syndrome according to the NCEP-ATP-III criteria
[15], the diagnosis of asthma and COPD after consultation
with a pulmonologist and pulmonary function tests, as
described below. The Epworth Sleepiness Scale [16]
questionnaire was used to assess OSAS, and the GERD
Questionnaire [17] for gastroesophageal reflux disease
(GERD).
All participating subjects gave informed consent. The local
ethics committee (Toetsingscommissie Wetenschappenlijk
Onderzoek Rotterdam e.o, trial number NL25637.101.08)
approved the study protocol (Netherlands Trial Register
number NTR3204).
Pulmonary Function Tests
Spirometry was performed with Vmax spirometer (Vmax
SensorMedics Viasys, type Encore 20/22/229/62 Encore,
Cardinal Health, USA) before and after 400 μg of inhaled
salbutamol, with subjects in a sitting position and nose
clips in place according to the American Thoracic
Society/European Respiratory Society statement [18]. All
values obtained were related to height, age, and gender
and were expressed as percentage of their predicted value
(reference ERS 1993). The pulmonary function test results
are shown as prebronchodilator values unless otherwise
indicated. The degree of reversibility in forced expiratory
volume in 1 s (FEV1), which indicates a diagnosis of asthma
is generally accepted as ≥12 % and 200 ml from the pre-
bronchodilator value (ΔFEV1 ≥12 %) [19]. Because many
lung diseases may result in reduced FEV1, a useful assess-
ment of airflow limitation is the ratio of FEV1 to FVC. The
FEV1/FVC ratio is normally greater than 70 %. Total lung
capacity could only be measured if subjects were <150 kg.
Exhaled nitric oxide (FeNO) was measured with Niox
mino (Aerocrine, Sweden) and expressed in parts per
billion (ppb) [20].
Bariatric Surgery
All operations were laparoscopic, either sleeve gastrectomy
[21] or Roux-en Y gastric bypass. Routine anesthesia was
applied with desflurane and remifentanil. Both procedures
were performed with the patient in a semi-reclining po-
sition (anti-Trendelenburg position) with the legs in split
upward position (French position). All patients routinely
received prophylaxis against deep venous thrombosis
with pneumatic compression stocking and subcutaneous
low molecular weight heparin during two weeks. Periop-
erative antibiotics (cefazoline 2 g) were also routinely
given. Patients were normally discharged the second day
after surgery.
Complications
The cumulative 30-days postoperative complications were
obtained from the patient charts and divided into pulmonary,
surgical, infectious, or other by a surgeon and a pulmonol-
ogist. The reasons for either hospital readmission or the
problem found at relaparoscopy were scored as complica-
tions, but readmission or relaparoscopy itself were not
scored as separate complications.
Statistical Analyses
Analysis was not restricted to pulmonary problems, but
included all complications. Patients were divided into
groups with and without complications. Unadjusted
between-group comparisons were performed using
Student’s t test or the Chi-square test (or Fisher’s Exact test,
where appropriate) and the Mann Whitney U test for non-
parametric comparisons. Multiple logistic regression analy-
sis (entered) was used to assess the relationship between
preoperative factors and the risk of postoperative complica-
tions adjusted for other co-variables. Baseline variables
associated with complications in univariate analysis at a p
value of <0.1 were examined in the logistic regression
analysis. Age, sex, BMI, and smoking status were added
to the regression analysis. Since FEV1 and FVC are associ-
ated, we used three different regression models which all
contained one of the pulmonary function parameters. All
analyses were performed using SPSS 18.0 software (SPSS
Inc., Chicago, Illinois, USA). A two-sided p<0.05 was
considered a statistically significant result.
Results
Four hundred eighty-five patients were included (mean
BMI 45.4 kg/m2, M/F 100:385). There were in total 53
complications in 50 patients (10.3 %) after bariatric sur-
gery (as specified in Table 1). There were 35 re-
admissions (7.2 %), of which seven patients were found
to have no complications. Relaparoscopy was performed
in 16 cases, relaparotomy in 1 case (total 3.5 %). All of
these subjects were found to have a complication (nine
hematoma, one spleen injury, one anastomosis leakage,
three anastomosis stenosis, two small bowel injuries, and
one abscess). No deaths occurred.
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Baseline characteristics did not differ between subjects
with or without complications (Table 2), especially not in
BMI, abdominal circumference or fat mass. The superobese
patients (BMI >50 kg/m2, n=104) did not have more com-
plications than the subjects with BMI <50 kg/m2 (n=381)
(10.6 % versus 10.2 %, p=0.92). There was no difference in
pre-existing comorbidities, e.g., asthma, diabetes, reflux
(assessed with GERD-Q), or sleep apnea syndrome
(assessed with ESS). There were no differences either in
operation technique used (sleeve gastrectomy or gastric
bypass) or in American Society of Anesthesiologists
(ASA) scoring between groups with or without complica-
tions. There was a trend towards longer operation duration
in subjects with complications, and the median length of
hospital stay was significantly longer in subjects with
complications (Table 2).
Subjects with complications had a significantly lower
FEV1 compared to subjects without complications (Table 3).
Subjects with complications more often had airflow revers-
ibility (increase in FEV1 after bronchodilatation of at least
12 %) and airway obstruction (FEV1/FVC <70 % predicted),
compared to subjects without complications. There was no
difference in TLC or FeNO between subjects with or without
complications.
Abnormal spirometry requiring an intervention by means
of additional medication, increased medication dose or
preoperative steroid course occurred more often in subjects
with complications (26 %) than in subjects without com-
plications (14 %, p=0.026). Subjects with a medication
advice did not have longer operation duration or length
of hospital stay.
Table 4 displays the results of three separate logistic
regression analyses, after adjustment for age, sex, BMI and
smoking status. Since FEV1 and FVC are correlated, we
used three different models which all contained one of
the pulmonary function parameters. Airway reversibility
(ΔFEV1 ≥12 %) and airway obstruction (FEV1/FVC
<70 %) remained significant predictors of complications.
Discussion
This study demonstrates that morbidly obese subjects with
abnormal preoperative spirometric results—more specif-
ically, airway obstruction (FEV1/FVC <70 % predicted)
(adjusted OR 3.1) or airflow reversibility (increase of
FEV1 ≥12 %) (adjusted OR 2.9)—are more likely to
develop postoperative complications after undergoing
laparoscopic bariatric surgery.
To our knowledge, this is the first study which has
investigated the association between preoperative pulmo-
nary function testing and complications after laparoscopic
bariatric surgery. Previous studies have investigated compli-
cations in open procedures [10] or both open and laparo-
scopic [22]. Furthermore, this study has also included sleeve
gastrectomy, a rather new surgical technique as a standalone
procedure. This study has used a large group of subjects,
who were all well characterized.
The American Society for Metabolic and Bariatric Center
of Excellence facilities report mentioned a 5 % readmission
rate and a 2 % reoperation rate [23], which compares well
with our rates (7 % and 3.5 % respectively). Also, our
complication rate of 10 % is comparable to other studies
(3 to 24 %). Surgical experience may have influenced the
complication rates. Some studies suggest that leakage is
more likely to occur when the surgeon is less experienced
[24]. In the present study, procedures were performed by an
experienced team in which each surgeon had carried out
over 200 procedures. Furthermore, the highly standardized
treatment protocol applied in our hospital, such as routine
prophylaxis against deep venous thrombosis with pneumatic
compression stocking and administration of subcutaneous
heparin, probably also prevented complications.
There is considerable debate regarding the role of preop-
erative pulmonary function testing for risk stratification. It
has been suggested that the test simply confirms the clinical
impression of disease severity in most cases, adding little to
the clinical estimation of risk of complications [25]. Conse-
quently, most patients with an abnormal spirometry test
Table 1 Postoperative complications
Frequency
Pulmonary complications 8 (1.6 %)
Pneumonia 5
Pulmonary embolism 1
Pneumothorax 1
Lung abscess 1
Surgical complications 27 (5.6 %)
Hematoma (intra-abdominal) 10
Spleen injury 3
Anastomotic leak 2
Anastomotic stenosis 3
Requirement for blood transfusion 4
Small bowel injury 2
Abscess (deep) 1
Stenosis (endoscopic dilatation) 1
Hypovolemic shock 1
Infectious complications 14 (2.9 %)
Urinary tract infection 4
Abdominal wall infection 8
Unknown 2
Other complications 4 (0.8 %)
Dehydration 3
Intensive care admission for hyperglycaemia 1
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result would also have been identified on the basis of history
and physical examination. Several critical remarks can be
made. First, lung function measurements and the presence
of symptoms are poorly associated [10]. Second, all studies
on the added value of preoperative spirometry were
conducted in a general population, and not in the specific
morbidly obese patient group undergoing bariatric surgery,
as described here. Since the morbidly obese can be seen as a
distinct group with a different physiology, it is questionable
whether results from the general population also apply to the
obese. One exception is Gonzalez et al. who investigated the
role of pulmonary function testing specifically in the mor-
bidly obese. They found that a FEV1 <80 % of predicted
increased the likelihood of complicated postoperative
management after Roux-en-Y gastric bypass [21]. They
combined open and laparoscopic operations, whereas we
only used the laparoscopic technique. Although the current
study does not support the data by Gonzalez et al, a similar
trend was found here (OR 1.9, p=0.07, Table 4). However,
our study found that FEV1/FVC <70 % (airflow obstruction)
and ΔFEV1 >12 % (airflow reversibility) increased the
likelihood of complicated bariatric surgery.
Airflow reversibility and airflow obstruction are hall-
marks of asthma. Valid comparisons with other studies are
limited. Other publications on the risk of complications of
bariatric surgery did not include asthma [3], or state that
well-controlled asthma is not a risk factor [8]. Although the
diagnosis of asthma is usually based on the presence of
Table 2 Baseline characteristics
of subjects
Unless stated otherwise, data
presented as mean±standard
deviation or percentage
OSAS obstructive sleep
apnea syndrome, GERD
gastroesophageal reflux disease,
ASA score American Society
of Anesthesiologists score
aData presented as median (IQR)
Subjects without complications Subjects with complications p value
N=435 N=50
Age (years) 41.6±11.1 40.7±10.8 0.603
Weight (kg) 131.0±22.4 136.1±28.5 0.229
Body mass index (kg/m2) 45.3±6.2 46.5±6.6 0.196
Abdominal circumference (cm) 131.6±14.9 133.1±17.0 0.536
Bioimpedance
Fat free mass (kg) 63.78±11.2 66.4±14.4 0.164
Fat (%) 50.5±7.0 51.4±6.9 0.425
Fat (kg) 66.9±16.3 71.2±18.9 0.117
Gender (% female) 79.5 % 78.0 % 0.799
Ethnicity (% Caucasian) 84.6 % 86.0 % 0.475
Smoking status 0.758
% Never 42 % 46 %
% Former 33 % 28 %
% Active 25 % 26 %
Pack yearsa 2.2 (0–12.5) 2.2 (0–14) 0.754
Comorbidity
Asthma 23.0 % 28.0 % 0.429
COPD 3.2 % 2.0 % 0.999
Diabetes mellitus 32.0 % 33.3 % 0.856
Hypertension 74.4 % 68.8 % 0.396
Hypercholesterolemia 35.8 % 43.8 % 0.281
Metabolic syndrome 64.6 % 64.6 % 0.993
Epworth sleepiness scale (OSAS)a 3 (2–4) 3 (1–4) 0.870
GERD questionnaire 6.9±2.3 6.4±1.9 0.455
Surgery
Operation (% sleeve gastrectomy) 63 % 58 % 0.470
Operation duration (min) 92.4±40.4 102.9±37.2 0.080
Admission (days)a 4 (3–4) 5 (4–7.25) <0.001
ASA scoring 0.835
1 (%) 0.2 % 0 %
2 (%) 36.8 % 34.1 %
3 (%) 60.5 % 61.4 %
4 (%) 2.4 % 4.5 %
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characteristic symptoms, in the morbidly obese, these symp-
toms are often unreliable [26]. It is known that asthma is
overdiagnosed by 30 % when self-reported asthma is used
[27]. The European Respiratory Society state in the Global
Initiative for Asthma guidelines that the measurement of
reversibility of lung function abnormalities greatly enhances
diagnostic confidence, and it also recommends that patients
with asthma undergo preoperative evaluation to assess asth-
ma control [18]. We advocate that spirometry should be part
of preoperative evaluation before bariatric surgery for the
following three reasons. First of all, this is because asthma is
50 % more prevalent among obese subjects [6], and obesity
is an important risk factor for severe asthma [7]. Secondly,
the diagnosis of asthma is more complicated in obese
subjects than in lean subjects. Finally, our results show
that spirometric tests can identify the patients at risk for
complications.
Interestingly, our study has shown that spirometry is not
only useful in predicting pulmonary complications, but it
might predict all complications of bariatric surgery. This it is
in line with previous findings that FEV1 is associated with
mortality [28–30]. FEV1 could possibly be a marker of
general health or fitness. So abnormal spirometry does not
only indicate obstructive pulmonary disease, but might also
indicate poor general health. In contrast to spirometry, the
American Society of Anesthesiologists physical status scale
Table 3 Pulmonary function tests
N Subjects without complications Subjects with complications p value
FEV1 (% predicted) 485 92.9±14.3 86.9±13.5 0.005
FEV1<80 % predicted 485 17.1 % 28.0 % 0.057
FVC (% predicted) 485 100.1±14.9 95.7±13.0 0.045
FVC<80 % predicted 485 9.0 % 10.0 % 0.813
FEV1/FVC (% predicted) 485 79.2±5.9 77.7±7.8 0.111
RV (% predicted, post) 212 76.9±20.4 76.5±14.3 0.941
FRC (% predicted, post) 212 66.0±13.2 66.1±12.3 0.993
TLC (% predicted, post) 212 94.8±11.2 95.2±8.4 0.889
Reversibility FEV1 (%) 485 4.3±4.9 5.5±7.7 0.315
FeNO (ppb)a 225 14.5 (9.0–22.0) 17.0 (9.5–23.5) 0.676
ΔFEV1≥12 % 485 7.2 % 18.4 % 0.007
FEV1/FVC<70 % predicted 485 8.1 % 20.0 % 0.006
Unless stated otherwise, data presented as mean±standard deviation or percentage
a Data presented as median (IQR)
FEV1 forced expiratory volume in 1 s, FVC forced vital capacity, RV residual volume, FRC functional respiratory capacity, TLC total lung capacity,
FeNO exhaled nitric oxide
Table 4 Multivariable logistic regression analysis of the risk of complications after laparoscopic bariatric surgery
Model I Model II Model III
Exp (B) 95 % CI p value Exp (B) 95 % CI p value Exp (B) 95 % CI p value
Age 0.992 0.966–1.019 0.558 0.990 0.964–1.017 0.466 0.992 0.965–1.019 0.548
Sex 0.903 0.443–1.843 0.780 1.045 0.504–2.171 0.905 0.892 0.434–1.832 0.755
BMI 1.028 0.982–1.076 0.238 1.032 0.986–1.081 0.176 1.018 0.970–1.068 0.469
Smoking statusa 1.017 0.515–2.010 0.961 0.958 0.480–1.915 0.904 1.063 0.535–2.112 0.861
Constant 0.043 0.015 0.034 0.011 0.068 0.051
FEV1<80 % predicted 1.865 0.953–3.652 0.069
FEV1/FVC<70 % predicted 3.057 1.370–6.823 0.006
ΔFEV1≥12 % 2.933 1.298–6.629 0.010
All models consisted of the variables age, sex, BMI and smoking status. Since FEV1 and FVC are associated, we used three different regression
models which all contained one of the pulmonary function parameters. Model I added FEV1 <80 % predicted as variable, model II added
FEV1/FVC <70 % predicted as variable, and model III added ΔFEV1 ≥12 % as variable
a Current smokers versus rest
FEV1 forced expiratory volume in 1 s, FVC forced vital capacity
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(ASA) appeared to be insensitive for predicting complica-
tions in this study.
Another study suggested that the super obese (BMI
>50 kg/m2) are more prone to complications of bariatric
surgery [31]. This study did not find this relationship in our
cohort, despite the fact that 21 % had a BMI >50 kg/m2.
Furthermore, this study found no difference in mean BMI,
body fat percentage, or abdominal circumference between the
subjects with and without complications. Therefore, this study
does not support that differences in fat distribution influence
the risk of complications of bariatric surgery.
Cawley and coworkers in a large cohort study showed
that subjects with obesity-related comorbidities prior to
bariatric surgery were at significantly elevated risk of
postsurgery complications [32]. In contrast, in our cohort
presurgical obesity-related comorbidities such as diabe-
tes mellitus, hypertension, hyperlipidemia, GERD or
OSAS were unrelated to complications. This might be
an effect of the extensive presurgical screening—and if
indicated treatment—for comorbidities as is standard in
our hospital [33].
There are several limitations. First of all, complications
were obtained from the patient charts, and may have been
subject to underreporting. Secondly, we did not perform
methacholine provocation tests, implying that a definite
diagnosis of asthma could not always be reached. Finally,
we did not perform a randomized study, so we cannot state
anything on the surplus value of spirometry. Furthermore,
the extensive presurgical screening program as incorporated
in our hospital could have reduced the incidence of compli-
cations. The low numbers of pulmonary complications in
our study did not allow for specific subgroup comparisons.
As symptoms are often unreliable in the morbidly obese,
pulmonary function tests should routinely be part of the
preoperative risk assessment. We have shown that subjects
with complications within 30 days of bariatric surgery more
often have airflow reversibility or airflow obstruction. Gen-
erally, laparoscopic bariatric surgery is safe, but randomized
prospective studies are needed to investigate whether abnor-
mal pulmonary functions tests could indeed serve as a guide
in patient selection and optimization of the preoperative
medical condition of patients undergoing bariatric surgery,
which could lead to additional improvement in the outcomes
after bariatric surgery.
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